CD93 and central nervous system cancer: First, we plotted the Kaplan–Meier models using the survival statistics from glioma samples from the TCGA and CGGA sets (Fig. 2a, b), and those patients with highly expressed CD93 exhibited significantly shorter overall survival (OS) time (P < 0.0001).